Schedule 13G ownership disclosure

IMPRIMIS PHARMACEUTICALS INC

Security class unavailable · CUSIP: 45323A201

Event date: 2017-03-21

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,416,000
Percent of class
7.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-17-021070
Form type
SC 13G/A
Filer
HARROW, INC.
CIK
CIK 1360214
Filed
Apr 19, 2017
Reporting period
Mar 21, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub